A 28-year-old man with a stab wound to the abdomen is brought to the emergency department with active bleeding. He is conscious but anxious, blood pressure 95/60 mmHg, heart rate 125/min, respiratory rate 24/min, SpO₂ 94% on room air. He ate dinner 1 hour ago. The surgical team requests immediate anesthesia for emergency laparotomy. During rapid sequence induction, after administration of the induction agent and neuromuscular blocker, the anesthesiologist observes fasciculations followed by a brief period of apnea. Which of the following best explains the mechanism of the apnea observed in this patient?

Explanation

## Succinylcholine and Neuromuscular Blockade in RSI ### Understanding Succinylcholine Mechanism **Key Point:** Succinylcholine is a depolarizing neuromuscular blocking agent that causes sustained depolarization at the motor endplate, resulting in visible fasciculations followed by flaccid paralysis and apnea. ### Mechanism of Action ```mermaid flowchart TD A[Succinylcholine administered IV]:::action --> B[Binds to nicotinic acetylcholine receptors]:::outcome B --> C[Sustained depolarization of motor endplate]:::outcome C --> D[Visible fasciculations - muscle contraction]:::action D --> E[Depolarization blockade - loss of repolarization]:::outcome E --> F[Flaccid paralysis of skeletal muscles]:::outcome F --> G[Paralysis of diaphragm and intercostal muscles]:::urgent G --> H[Apnea - inability to generate spontaneous ventilation]:::urgent ``` ### Phases of Succinylcholine Blockade | Phase | Characteristics | Duration | Clinical Finding | |-------|-----------------|----------|------------------| | **Phase I (Depolarizing)** | Sustained depolarization, fasciculations visible, apnea | 5–10 sec | Muscle twitching, then paralysis | | **Phase II (Desensitization)** | Prolonged blockade, fade on train-of-four, post-tetanic potentiation | Variable | Prolonged paralysis in pseudocholinesterase deficiency | **High-Yield:** The apnea observed is due to paralysis of the diaphragm and intercostal muscles — the patient CANNOT breathe spontaneously because the neuromuscular junction is blocked, not because of CNS depression. ### Why This Patient Requires Immediate Intubation 1. **Onset of paralysis:** 30–60 seconds after IV administration. 2. **Duration:** 5–10 minutes (allows time for intubation and initial surgical preparation). 3. **Apnea management:** The anesthesiologist must immediately provide positive pressure ventilation (bag-mask ventilation) or intubate the trachea to maintain oxygenation and ventilation. **Clinical Pearl:** In a hemorrhagic shock patient (BP 95/60, HR 125), succinylcholine is still acceptable because: - Rapid onset is critical for airway security in emergency surgery. - Hyperkalemia risk from succinylcholine is less concerning than aspiration risk in this acute setting. - Etomidate or ketamine (not propofol) should be used as induction agent to preserve hemodynamics. ### Succinylcholine Fasciculations and Complications **Mnemonic: FASCICULATIONS** — Fasciculations cause: - **F**asciculations (visible muscle twitching) - **A**cetylcholine depletion at motor endplate - **S**uccinylcholine-induced hyperkalemia (especially in burns, crush injury, denervation) - **C**ontraction of muscles → increased intragastric pressure, intraocular pressure - **I**ncreased serum potassium (K⁺ rise of 0.5–1 mEq/L) - **C**ardiac arrhythmias possible in hyperkalemia-risk patients - **U**ndesirable muscle damage in myopathies - **L**aryngeal spasm risk if inadequate depth - **A**pnea (paralysis of respiratory muscles) - **T**rismus and jaw clenching - **I**ncreased intracranial pressure - **O**phthalmoplegia (extraocular muscle paralysis) - **N**euromuscular blockade (desired effect) - **S**uccinylcholine phase I blockade **Warning:** To prevent fasciculation-related complications (hyperkalemia, increased ICP, increased gastric pressure), a small dose of non-depolarizing agent (e.g., rocuronium 0.01 mg/kg) can be given 3–5 minutes before succinylcholine — this is called "defasciculation" and is optional in routine RSI but recommended in at-risk patients.